TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

ENHERTU (TRASTUZUMAB DERUXTECAN) 100MG POWDER FOR CONCENTRATE FOR SOLN FOR INFUSION VIAL

No classification published
Location not published
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: Belfast Health and Social Care Trust: "ENHERTU (TRASTUZUMAB DERUXTECAN) 100MG POWDER FOR CONCENTRATE FOR SOLN FOR INFUSION VIAL". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityBelfast Health and Social Care TrustScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: Belfast Health and Social Care Trust
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for Belfast Health and Social Care Trust. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
10Bids / Report
8% of reports have one bid
Supplier ConcentrationHigh Concentration
MET HEALTHCARE LIMITEDTop vendor: 84.5% of attributable value
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 81 active published awards; 25 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Historical Awarded Suppliers With This Authority:
Supplier NameHistoric AwardsAttributable GBP Value
MET HEALTHCARE LIMITED1 win£935,340
RESUSCITATION COUNCIL (UK)1 win£171,640
Procedure terms
Contracting AuthorityBelfast Health and Social Care Trust
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSNot published
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published6 Jun 2025, 14:12 BST
Last source update6 Jun 2025, 14:12 BST
Recurring procurementNot published
ClassificationNot published
Delivery areaLocation not published
OCIDocds-h6vhtk-051a06
What is being bought
Procurement of ENHERTU (TRASTUZUMAB DERUXTECAN) 100MG POWDER FOR CONCENTRATE FOR SOLN FOR INFUSION VIAL
What changed
From the official release history
  1. Official notice release published
    6 Jun 2025, 14:12 BST
  2. Official notice release published
    21 May 2025, 10:52 BST
  3. Status changed to complete
    21 May 2025, 10:47 BST
  4. Official notice release published
    21 May 2025, 10:47 BST
  5. Buyer information updated
    21 May 2025, 10:47 BST
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    complete
    Published valueNot published
    The source published no individual title or description for this lot.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    6 Jun 2025, 14:12 BST
  2. Award active
    Not published · Not published
  3. Contract active
    Signed 3 Jun 2025, 00:00 BST · £750,000
Commercial outcome and competition
Awards
ALLOGA UK LIMITED
Not published · Not published · active
Contracts
ENHERTU (TRASTUZUMAB DERUXTECAN) 100MG POWDER FOR CONCENTRATE FOR SOLN FOR INFUSION VIAL,
£750,000 · signed 3 Jun 2025, 00:00 BST · active
Contract period: 3 Jun 2025, 00:00 BST — 30 Jun 2027, 23:59 BST
Bid statisticsNo aggregate bid statistics published
Buyer and organisations in this procedure

Belfast Health and Social Care Trust

Contracting authority GB-PPON-PLQJ-5727-JCLR
View buyer profile

  • Belfast Health & Social Care Trust
    buyer

    GB-PPON: PLQJ-5727-JCLR
    Trust Headquarters, 2nd Floor, Non Clinical Support Building, Royal Victoria Hospital, Belfast, UKN06, BT12 6BA, GB
    FinanceProcurement@belfasttrust.hscni.net

  • ALLOGA UK LIMITED
    supplier

    GB-COH: 03169255 · GB-PPON: PBTH-6754-GVPN
    Amber Park, Alfreton, UKF12, DE55 2FH, GB
    allogauk.enquiries@alloga.co.uk
Documents (1)
Official links; attachments are not copied

  • Not published

    tender
    conflictOfInterest
Related procedures (0)
No data
No related procedures published
Planning and rationale
Planning budgetNot published
No-engagement rationaleNot published
Procedure rationaleThese essential medicines are required for continuity of patient care. These medicines are available only from one economic operator. BHSCT can confirm that the absence of competition is not a result of the artificial narrowing of the parameters of the procurement.